An overview on recent approaches for colonic drug delivery systems

References

• Abdelmegid AM, Abdo FK, Ahmed FE, Kattaia AaA 2019. Therapeutic effect of gold nanoparticles on DSS-induced ulcerative colitis in mice with reference to interleukin-17 expression. Sci Rep. 9(1):10176. doi: 10.1038/s41598-019-46671-1.
   PubMed Web of Science ®Google Scholar
• Aib S, Iqbal K, Khan N, Khalid S, Adnan M, Umair SM, Dar MJ. 2022. pH-sensitive liposomes for colonic co-delivery of mesalazine and curcumin for the treatment of ulcerative colitis. J Drug Delivery Sci Technol. 72:103335. doi: 10.1016/j.jddst.2022.103335.
   Web of Science ®Google Scholar
• Ajorlou E, Khosroushahi AY. 2016. Trends on polymer- and lipid-based nanostructures for parenteral drug delivery to tumors. Cancer Chemother Pharmacol. 79(2):251–265. doi: 10.1007/s00280-016-3168-6.
   PubMed Web of Science ®Google Scholar
• Alaaeldin E, Refaat H, Saber EA, Aziz NM, Abdel-Maqsoud NMR, Aleem MMaE, Kamel MY, Mady FM. 2023. Co-administration of thymoquinone and propolis in liposomal formulations as a potential approach for treatment of acetic acid-induced ulcerative colitis: physiological and histopathological analysis. AAPS PharmSciTech. 24(7):190. doi: 10.1208/s12249-023-02637-1.
   PubMed Web of Science ®Google Scholar
• Alajami HN, Fouad EA, Ashour AE, Kumar A, Yassin AEB. 2022. Celecoxib-Loaded solid lipid nanoparticles for colon delivery: formulation optimization and in vitro assessment of Anti-Cancer activity. Pharmaceutics. 14(1):131. doi: 10.3390/pharmaceutics14010131.
   PubMed Web of Science ®Google Scholar
• Amidon S, Brown J, Dave VS. 2015. Colon-targeted oral drug delivery systems: design trends and approaches. AAPS PharmSciTech. 16(4):731–741. doi: 10.1208/s12249-015-0350-9.
   PubMed Web of Science ®Google Scholar
• Annaji M, Poudel I, Boddu SHS, Arnold RD, Tiwari AK, Babu RJ. 2021. Resveratrol‐loaded nanomedicines for cancer applications. Cancer Reports. 4(3):e1353. doi: 10.1002/cnr2.1353.
   Google Scholar
• Arduino I, Liu Z, Rahikkala A, Figueiredo P, Correia A, Cutrignelli A, Denora N, Santos HA. 2021. Preparation of cetyl palmitate-based PEGylated solid lipid nanoparticles by microfluidic technique. Acta Biomater. 121:566–578. doi: 10.1016/j.actbio.2020.12.024.
   PubMed Web of Science ®Google Scholar
• Arun N, Rishika D, Nagasamy Venkatesh D. 2023. Colorectal cancer current treatments and its novel drug delivery systems. J Med Pharmaceut Allied Sci. 12(1):5588–5595. doi: 10.55522/jmpas.V12I1.4391
   Google Scholar
• Awad A, Madla CM, McCoubrey LE, Ferraro F, Gavins FK, Buanz A, Gaisford S, Orlu M, Siepmann F, Siepmann J, et al. 2022. Clinical translation of advanced colonic drug delivery technologies. Adv Drug Deliv Rev. 181:114076. doi: 10.1016/j.addr.2021.114076.
   PubMed Web of Science ®Google Scholar
• Azhar SNaS, Ashari SE, Zainuddin N, Hassan M. 2022. Nanostructured lipid carriers-hydrogels system for drug delivery: nanohybrid technology perspective. Molecules. 27(1):289. doi: 10.3390/molecules27010289.
   PubMed Web of Science ®Google Scholar
• Bharti D, Medicherla K, Pooja D, Kulhari H. 2023. Dendrimer-mediated delivery of anticancer drugs for colon cancer treatment. Pharmaceutics. 15(3):801. doi: 10.3390/pharmaceutics15030801.
   PubMed Web of Science ®Google Scholar
• Bhaskaran, Navya Ajitkumar, Jitta, Srinivas Reddy, Cheruku, SriPragnya, Kumar, Nitesh, Kumar, Lalit, Salwa, (2022). Orally delivered solid lipid nanoparticles of irinotecan coupled with chitosan surface modification to treat colon cancer: preparation, in-vitro and in-vivo evaluations.Int J Biol Macromol, 211, 301–315. doi: 10.1016/j.ijbiomac.2022.05.060.
   PubMed Web of Science ®Google Scholar
• Brayden DJ, Hill TA, Fairlie DP, Maher S, Mrsny R. 2020. Systemic delivery of peptides by the oral route: formulation and medicinal chemistry approaches. Adv Drug Deliv Rev. 157:2–36. doi: 10.1016/j.addr.2020.05.007.
   PubMed Web of Science ®Google Scholar
• Campos FL, De Alcântara Lemos J, Oda CMR, De Oliveira Silva J, Fernandes RS, Miranda SEM, Cavalcante CH, Cassali GD, Townsend DM, Leite EA, et al. 2022. Irinotecan-Loaded polymeric micelles as a promising alternative to enhance antitumor efficacy in colorectal cancer therapy. Polymers (Basel). 14(22):4905. doi: 10.3390/polym14224905.
   PubMed Web of Science ®Google Scholar
• Casati F, Melocchi A, Moutaharrik S, Uboldi M, Foppoli A, Maroni A, Zema L, Neut C, Florence S, Siepmann J, et al. 2020. Injection molded capsules for colon delivery combining time-controlled and enzyme-triggered approaches. Int J Mol Sci. 21(6):1917. doi: 10.3390/ijms21061917.
   PubMed Web of Science ®Google Scholar
• Cavalcante CH, Fernandes RS, De Oliveira Silva J, Oda CMR, Leite EA, Cassali GD, Charlie-Silva I, Fernandes BHV, Ferreira LaM, De Barros ALB. 2021. Doxorubicin-loaded pH-sensitive micelles: a promising alternative to enhance antitumor activity and reduce toxicity. Biomed Pharmacother. 134:111076. doi: 10.1016/j.biopha.2020.111076.
   PubMed Web of Science ®Google Scholar
• Chan RP, Pope DJ, Gilbert AP, Sacra P, Baron JH, Lennard‐Jones JE. 1983. Studies of two novel sulfasalazine analogs, ipsalazide and balsalazide. Dig Dis Sci. 28(7):609–615. doi: 10.1007/bf01299921.
   PubMed Web of Science ®Google Scholar
• Crouwel F, Buiter HJC, De Boer NK. 2020. Gut microbiota-driven drug metabolism in inflammatory bowel disease. J Crohn’s Colitis. 15(2):307–315. doi: 10.1093/ecco-jcc/jjaa143.
   Google Scholar
• Deng J, Wu Z, Zhao Z, Wu C, Yuan M, Su Z, Wang Y, Wang Z. 2020. Berberine-loaded nanostructured lipid carriers enhance the treatment of ulcerative colitis. Int J Nanomedicine. 15:3937–3951. doi: 10.2147/ijn.s247406.
   PubMed Web of Science ®Google Scholar
• Effinger A, M O'Driscoll C, McAllister M, Fotaki N. 2020. Gastrointestinal diseases and their impact on drug solubility: ulcerative colitis. Eur J Pharm Sci. 152:105458. doi: 10.1016/j.ejps.2020.105458.
   PubMed Web of Science ®Google Scholar
• Effinger A, O'Driscoll CM, McAllister M, Fotaki N. 2021. Predicting budesonide performance in healthy subjects and patients with Crohn’s disease using biorelevant in vitro dissolution testing and PBPK modeling. Eur J Pharm Sci. 157:105617. doi: 10.1016/j.ejps.2020.105617.
   PubMed Web of Science ®Google Scholar
• Elkhodiry MA, Momah CC, Suwaidi SR, Gadalla D, Martins AM, Vitor RF, Husseini GA. 2016. Synergistic nanomedicine: passive, active, and ultrasound-triggered drug delivery in cancer treatment. J Nanosci Nanotechnol. 16(1):1–18. doi: 10.1166/jnn.2016.11124.
   PubMed Web of Science ®Google Scholar
• El-Enin HaA, Alquthami AF, Alwagdani AM, Yousef LM, Albuqami MS, Alharthi MA, Alsaab HO. 2022. Utilizing TPGS for optimizing quercetin nanoemulsion for colon cancer cells inhibition. Colloids and Interfaces. 6(3):49. doi: 10.3390/colloids6030049.
   Web of Science ®Google Scholar
• England R, Hare JI, Barnes JC, Wilson J, Smith A, Strittmatter N, Kemmitt PD, Waring MJ, Barry ST, Alexander C, et al. 2017. Tumour regression and improved gastrointestinal tolerability from controlled release of SN-38 from novel polyoxazoline-modified dendrimers. J Control Release. 247:73–85. doi: 10.1016/j.jconrel.2016.12.034.
   PubMed Web of Science ®Google Scholar
• Escalante P, Quiñones LA, Contreras HR. 2021. Epithelial-mesenchymal transition and microRNAs in colorectal cancer chemoresistance to FOLFOX. Pharmaceutics. 13(1):75. doi: 10.3390/pharmaceutics13010075.
   PubMed Web of Science ®Google Scholar
• González-Domínguez JM, Grasa L, Frontiñán-Rubio J, Abás E, Domínguez-Alfaro A, Mesonero JE, Criado A, Ansón-Casaos A. 2022. Intrinsic and selective activity of functionalized carbon nanotube/nanocellulose platforms against colon cancer cells. Colloids Surf B Biointerfaces. 212:112363. doi: 10.1016/j.colsurfb.2022.112363.
   PubMed Web of Science ®Google Scholar
• Handali S, Moghimipour E, Rezaei M, Ramezani Z, Kouchak M, Amini M, Angali KA, Saremy S, Dorkoosh FA. 2018. A novel 5-fluorouracil targeted delivery to colon cancer using folic acid conjugated liposomes. Biomed Pharmacother. 108:1259–1273. doi: 10.1016/j.biopha.2018.09.128.
   PubMed Web of Science ®Google Scholar
• Hatton GB, Madla CM, Rabbie SC, Basit AW. 2019. Gut reaction: impact of systemic diseases on gastrointestinal physiology and drug absorption. Drug Discov Today. 24(2):417–427. doi: 10.1016/j.drudis.2018.11.009.
   PubMed Web of Science ®Google Scholar
• Homayun B, Kumar A, Nascimento PTH, Choi H. 2018. Macropored microparticles with a core–shell architecture for oral delivery of biopharmaceuticals. Arch Pharm Res. 41(8):848–860. doi: 10.1007/s12272-018-1062-y.
   PubMed Web of Science ®Google Scholar
• Ibaraki H, Hatakeyama N, Arima N, Takeda A, Seta Y, Kanazawa T. 2022. Systemic delivery of siRNA to the colon using peptide modified PEG-PCL polymer micelles for the treatment of ulcerative colitis. Eur J Pharm Biopharm. 170:170–178. doi: 10.1016/j.ejpb.2021.12.009.
   PubMed Web of Science ®Google Scholar
• Jin X, Xia X, Li J, Adu-Frimpong M, Wang X, Wang Q, Wu H, Yu Q, Ji H, Toreniyazov E, et al. 2023. Preparation, characterization, pharmacokinetics and ulcerative colitis treatment of hyperoside-loaded mixed micelles. Drug Deliv Transl Res. 14(5):1370–1388. doi: 10.1007/s13346-023-01470-0.
   PubMed Web of Science ®Google Scholar
• Kaur J, Gulati M, Gowthamarajan K, Vishwas S, Kumar Chellappan D, Gupta G, Dua K, Pandey NK, Kumar B, Singh SK. 2021. Combination therapy of vanillic acid and oxaliplatin co-loaded in polysaccharide based functionalized polymeric micelles could offer effective treatment for colon cancer: a hypothesis. Med Hypotheses. 156:110679. doi: 10.1016/j.mehy.2021.110679.
   PubMed Web of Science ®Google Scholar
• Keshavarz F, Soltanshahi M, Khosravani F, Bakhshiyan F, Ghanbari A, Hassanzadeh S, Amirpour M, Ghalamfarsa G. 2024. Thymol-loaded liposomes effectively induced apoptosis and decreased EGFR expression in colorectal cancer cells. Naunyn-Schmiedeberg’s Arch Pharmacol. Epub ahead of print. doi: 10.1007/s00210-024-02945-8.
   Google Scholar
• Khalid S, Salman S, Iqbal K, Rehman FU, Ullah I, Satoskar AR, Khan GM, Dar MJ. 2022. Surfactant free synthesis of cationic nano-vesicles: a safe triple drug loaded vehicle for the topical treatment of cutaneous leishmaniasis. Nanomedicine. 40:102490. doi: 10.1016/j.nano.2021.102490.
   PubMed Web of Science ®Google Scholar
• Khan AA, Piris J, Truelove SC. 1977. An experiment to determine the active therapeutic moiety of sulphasalazine. Lancet. 2(8044):892–895. doi: 10.1016/s0140-6736(77)90831-5.
   PubMed Web of Science ®Google Scholar
• Kovochich M, Fung CD, Avanasi R, Madl AK. 2017. Review of techniques and studies characterizing the release of carbon nanotubes from nanocomposites: implications for exposure and human health risk assessment. J Expo Sci Environ Epidemiol. 28(3):203–215. doi: 10.1038/jes.2017.6.
   PubMed Web of Science ®Google Scholar
• Kraisit P. 2019. Impact of hydroxypropyl methylcellulose (hpmc) type and concentration on the swelling and release properties of propranolol hydrochloride matrix tablets usning a simplex centroid design. Int J App Pharm. 11(2):143–151. doi: 10.22159/ijap.2019v11i2.31127.
   PubMedGoogle Scholar
• Kulhari H, Pooja D, Singh M, Chauhan AS. 2013. Optimization of carboxylate-terminated poly(amidoamine) dendrimer-mediated cisplatin formulation. Drug Dev Ind Pharm. 41(2):232–238. doi: 10.3109/03639045.2013.858735.
   PubMed Web of Science ®Google Scholar
• Kumar G, Virmani T, Sharma A, Pathak K. 2023. Codelivery of phytochemicals with conventional anticancer drugs in form of nanocarriers. Pharmaceutics. 15(3):889. doi: 10.3390/pharmaceutics15030889.
   PubMed Web of Science ®Google Scholar
• Lemmens G, Van Camp A, Kourula S, Vanuytsel T, Augustijns P. 2021. Drug disposition in the lower gastrointestinal tract: targeting and monitoring. Pharmaceutics. 13(2):161. doi: 10.3390/pharmaceutics13020161.
   PubMed Web of Science ®Google Scholar
• Li C, Xu J, Gan Y, Liang X. 2020. Innovative Irinotecan-Loaded nanomicelles will enter Phase I clinical trial in 2021. The Innovation. 1(3):100057. doi: 10.1016/j.xinn.2020.100057.
   PubMedGoogle Scholar
• Li M, Liu J, Shi L, Zhou C, Zou M, Fu D, Yuan Y, Yao C, Zhang L, Qin S, et al. 2023. Gold nanoparticles-embedded ceria with enhanced antioxidant activities for treating inflammatory bowel disease. Bioact Mater. 25:95–106. doi: 10.1016/j.bioactmat.2023.01.015.
   PubMed Web of Science ®Google Scholar
• Li W, Li X, Liu S, Yang W, Fan P, Yang X, Du B, Li Q, Pan Y. 2017. Gold nanoparticles attenuate metastasis by tumor vasculature normalization and epithelial-mesenchymal transition inhibition. Int J Nanomedicine. 12:3509–3520. volume doi: 10.2147/ijn.s128802.
   PubMed Web of Science ®Google Scholar
• Li Z, Liu C, Li C, Wang F, Liu J, Zheng Z, Wu J, Zhang B. 2021. Irinotecan/scFv co-loaded liposomes coaction on tumor cells and CAFs for enhanced colorectal cancer therapy. J Nanobiotechnol. 19(1):421. doi: 10.1186/s12951-021-01172-0.
   Web of Science ®Google Scholar
• Lu Z, Liu J, Zhao L, Wang C, Shi F, Li Z, Liu X, Miao Z. 2023. Enhancement of oral bioavailability and anti-colitis effect of luteolin-loaded polymer micelles with RA (rosmarinic acid)-SS-mPEG as carrier. Drug Dev Ind Pharm. 49(1):17–29. doi: 10.1080/03639045.2023.2175850.
   PubMed Web of Science ®Google Scholar
• Mager LF, Burkhard R, Pett N, Cooke NCA, Brown K, Ramay HR, Paik SY, Stagg J, Groves RA, Gallo M, et al. 2020. Microbiome-derived inosine modulates response to checkpoint inhibitor immunotherapy. Science. 369(6510):1481–1489. doi: 10.1126/science.abc3421.
   PubMed Web of Science ®Google Scholar
• Major G, Murray K, Singh G, Nowak A, Hoad C, Marciani L, Silos-Santiago A, Kurtz CB, Johnston JM, Gowland P, et al. 2018. Demonstration of differences in colonic volumes, transit, chyme consistency, and response to psyllium between healthy and constipated subjects using magnetic resonance imaging. Neurogastroenterol Motil. 30(9):e13400. doi: 10.1111/nmo.13400.
   PubMed Web of Science ®Google Scholar
• Makeen HA, Mohan S, Al-Kasim MA, Attafi IM, Ahmed RA, Syed NK, Sultan MH, Al-Bratty M, Alhazmi HA, Safhi MM, et al. 2020. Gefitinib loaded nanostructured lipid carriers: characterization, evaluation and anti-human colon cancer activity in vitro. Drug Deliv. 27(1):622–631. doi: 10.1080/10717544.2020.1754526.
   PubMed Web of Science ®Google Scholar
• Mishra R, Ahmad A, Kumar A, Vyawahare A, Raza SS, Khan R. 2020. Lipid-based nanocarrier-mediated targeted delivery of celecoxib attenuate severity of ulcerative colitis. Mater Sci Eng C Mater Biol Appl. 116:111103. doi: 10.1016/j.msec.2020.111103.
   PubMed Web of Science ®Google Scholar
• Mishra RK, Ahmad A, Kumar A, Ali A, Kanika N, Jori C, Tabrez S, Zughaibi TA, Almashjary MN, Raza SS, et al. 2023. Cortisone-loaded stearoyl ascorbic acid based nanostructured lipid carriers alleviate inflammatory changes in DSS-induced colitis. BiomaterialsAdvances. 148:213383. doi: 10.1016/j.bioadv.2023.213383.
   Web of Science ®Google Scholar
• Misra SK, Pathak K. 2023. Nose-to-Brain targeting via nanoemulsion: significance and evidence. Colloids Interfaces. 7(1):23. doi: 10.3390/colloids7010023.
   Google Scholar
• Mohamed JMM, Ahmad F, El-Sherbiny M, Mohaini MaA, Venkatesan K, Alrashdi YBA, Eldesoqui MB, Ibrahim AE, Dawood AF, Ibrahim AM, et al. 2024. Optimization and characterization of quercetin-loaded solid lipid nanoparticles for biomedical application in colorectal cancer. Cancer Nano. 15(1):16. doi: 10.1186/s12645-024-00249-3.
   Web of Science ®Google Scholar
• Motawea A, Hady WEaE, El-Emam GA. 2022. The protective impact of adapted trimebutine maleate-loaded nanostructured lipid carriers for alleviating the severity of acute colitis. Drug Deliv. 29(1):906–924. doi: 10.1080/10717544.2022.2050847.
   PubMed Web of Science ®Google Scholar
• Moutaharrik S, Maroni A, Melocchi A, Zema L, Foppoli A, Cerea M, Palugan L, Neut C, Siepmann F, Siepmann J, et al. 2021. Oral colon delivery platform based on a novel combination approach: design concept and preliminary evaluation. J Drug Delivery Sci Technol. 66:102919. doi: 10.1016/j.jddst.2021.102919.
   Web of Science ®Google Scholar
• Nunes SS, Miranda SEM, De Oliveira Silva J, Fernandes RS, De Alcântara Lemos J, De Aguiar Ferreira C, Townsend DM, Cassali GD, Oliveira MC, De Barros ALB. 2021. pH-responsive and folate-coated liposomes encapsulating irinotecan as an alternative to improve efficacy of colorectal cancer treatment. Biomed Pharmacother. 144:112317. doi: 10.1016/j.biopha.2021.112317.
   PubMed Web of Science ®Google Scholar
• Oda CMR, De Oliveira Silva J, Fernandes RS, Braga AV, Machado RR, De Matos Coelho M, Cassali GD, Reis DCD, De Barros ALB, Leite EA. 2020. Encapsulating paclitaxel in polymeric nanomicelles increases antitumor activity and prevents peripheral neuropathy. Biomed Pharmacother. 132:110864. doi: 10.1016/j.biopha.2020.110864.
   PubMed Web of Science ®Google Scholar
• Peiris M, Aktar R, Reed DE, Cibert-Goton V, Zdanaviciene A, Halder W, Robinow A, Corke S, Dogra H, Knowles CH, et al. 2021. Decoy bypass for appetite suppression in obese adults: role of synergistic nutrient sensing receptors GPR84 and FFAR4 on colonic endocrine cells. Gut. 71(5):928–937. doi: 10.1136/gutjnl-2020-323219.
   PubMed Web of Science ®Google Scholar
• Perumal S. 2022. Polymer nanoparticles: synthesis and applications. Polymers (Basel). 14(24):5449. doi: 10.3390/polym14245449.
   PubMed Web of Science ®Google Scholar
• Randive DS, Shejawal KP, Bhinge SD, Bhutkar MA, Jadhav NR, Patil SB, Nadaf SJ. 2023. Efficient in vitro oxaliplatin delivery with functionalized single-walled carbon nanotube for enhanced colon cancer treatment. Futur J Pharm Sci. 9(1):91. doi: 10.1186/s43094-023-00543-8.
   Web of Science ®Google Scholar
• Salve PS. 2011. Development and in vitro evaluation colon targeted drug delivery system using natural gums. Asian J Pharma Res. 1(4):91–101.
   Google Scholar
• Santalices I, Gonella A, Torres D, Alonso MJ. 2017. Advances on the formulation of proteins using nanotechnologies. J Drug Delivery Sci Technol. 42:155–180. doi: 10.1016/j.jddst.2017.06.018.
   Web of Science ®Google Scholar
• Sardou HS, Akhgari A, Mohammadpour AH, Namdar AB, Kamali H, Jafarian AH, Garekani HA, Sadeghi F. 2022. Optimization study of combined enteric and time-dependent polymethacrylates as a coating for colon targeted delivery of 5-ASA pellets in rats with ulcerative colitis. Eur J Pharm Sci. 168:106072. doi: 10.1016/j.ejps.2021.106072.
   PubMed Web of Science ®Google Scholar
• Riley SA. 1998. What dose of 5-aminosalicylic acid (mesalazine) in ulcerative colitis? Gut. 42(6):761–763. doi: 10.1136/gut.42.6.761.
   PubMed Web of Science ®Google Scholar
• Shabana S, Hamouda HI, Hamadou AH, Ahmed B, Chi Z, Liu C. 2024. Marine phospholipid nanoliposomes: a promising therapeutic approach for inflammatory bowel disease: preparation, safety, and efficacy evaluation. Colloids Surf B Biointerfaces. 234:113702. doi: 10.1016/j.colsurfb.2023.113702.
   PubMed Web of Science ®Google Scholar
• Shakeel F, Haq N, Al-Dhfyan A, Alanazi FK, Alsarra IA. 2014. Double w/o/w nanoemulsion of 5-fluorouracil for self-nanoemulsifying drug delivery system. J Mol Liq. 200:183–190. doi: 10.1016/j.molliq.2014.10.013.
   Web of Science ®Google Scholar
• Shakeel F, Haq N, El-Badry M, Alanazi FK, Alsarra IA. 2013. Ultra fine super self-nanoemulsifying drug delivery system (SNEDDS) enhanced solubility and dissolution of indomethacin. J Mol Liq. 180:89–94. doi: 10.1016/j.molliq.2013.01.008.
   Web of Science ®Google Scholar
• Shejawal KP, Randive DS, Bhinge SD, Bhutkar MA, Wadkar GH, Todkar SS, Mohite SK. 2021. Functionalized carbon nanotube for colon-targeted delivery of isolated lycopene in colorectal cancer: ın vitro cytotoxicity and in vivo roentgenographic study. J Mater Res. 36(24):4894–4907. doi: 10.1557/s43578-021-00431-y.
   Web of Science ®Google Scholar
• Shi F, Yin W, Adu-Frimpong M, Li X, Xia X, Sun W, Ji H, Toreniyazov E, Qilong W, Cao X, et al. 2023. In-vitro and in-vivo evaluation and anti-colitis activity of esculetin-loaded nanostructured lipid carrier decorated with DSPE-MPEG2000. J Microencapsul. 40(6):442–455. doi: 10.1080/02652048.2023.2215345.
   PubMed Web of Science ®Google Scholar
• Shirodkar RK, Kumar L, Mutalik S, Lewis S. 2019. Solid lipid nanoparticles and nanostructured lipid carriers: emerging lipid based drug delivery systems. Pharm Chem J. 53(5):440–453. doi: 10.1007/s11094-019-02017-9.
   Web of Science ®Google Scholar
• Singh AP, Biswas A, Shukla A, Maiti P. 2019. Targeted therapy in chronic diseases using nanomaterial-based drug delivery vehicles. Signal Transduct Target Ther. 4(1):33. doi: 10.1038/s41392-019-0068-3.
   PubMedGoogle Scholar
• Sopyan I, Komarudin AD, Huang JA, Sunan IS. 2023. An overview: development of colon drug delivery system and its application and limitations. Int J App Pharm. 15(1):24–30. doi: 10.22159/ijap.2023v15i1.46681.
   PubMedGoogle Scholar
• Stillhart C, Vučićević K, Augustijns P, Basit AW, Batchelor H, Flanagan T, Gesquiere I, Greupink R, Keszthelyi D, Koskinen M, et al. 2020. Impact of gastrointestinal physiology on drug absorption in special populations––An UNGAP review. Eur J Pharm Sci. 147:105280. doi: 10.1016/j.ejps.2020.105280.
   PubMed Web of Science ®Google Scholar
• Tefas LR, Toma I, Sesarman A, Banciu M, Jurj A, Berindan-Neagoe I, Rus L, Stiufiuc R, Tomuta I. 2022. Co-delivery of gemcitabine and salinomycin in PEGylated liposomes for enhanced anticancer efficacy against colorectal cancer. J Liposome Res. 33(3):234–250. doi: 10.1080/08982104.2022.2153139.
   PubMed Web of Science ®Google Scholar
• Testa A, Castiglione F, Nardone OM, Colombo GL. 2017. Adherence in ulcerative colitis: an overview. Patient Prefer Adherence. 11:297–303. doi: 10.2147/ppa.s127039.
   PubMed Web of Science ®Google Scholar
• Thakur CK, Neupane R, Karthikeyan C, Ashby CR, Babu RJ, Boddu SHS, Tiwari AK, Moorthy NSHN. 2022. Lysinated multiwalled carbon nanotubes with carbohydrate ligands as an effective nanocarrier for targeted doxorubicin delivery to breast cancer cells. Molecules. 27(21):7461. doi: 10.3390/molecules27217461.
   PubMed Web of Science ®Google Scholar
• Trivedi HD, Puranik PK. 2017. Colon targeted delivery system (codestm): propitious approach in targeting colon. WJPPS. 6(4):768–789. doi: 10.20959/wjpps20174-8951.
   Google Scholar
• Tubic-Grozdanis M, Hilfinger JM, Amidon GL, Kim JS, Kijek P, Staubach P, Langguth P. 2008. Pharmacokinetics of the CYP 3A substrate simvastatin following administration of delayed versus immediate release oral dosage forms. Pharm Res. 25(7):1591–1600. doi: 10.1007/s11095-007-9519-6.
   PubMed Web of Science ®Google Scholar
• Varum F, Freire AC, Bravo R, Basit AW. 2020b. OPTICORETM, an innovative and accurate colonic targeting technology. Int J Pharm. 583:119372. doi: 10.1016/j.ijpharm.2020.119372.
   PubMedGoogle Scholar
• Varum F, Freire AC, Fadda HM, Bravo R, Basit AW. 2020a. A dual pH and microbiota-triggered coating (PhloralTM) for fail-safe colonic drug release. Int J Pharm. 583:119379. doi: 10.1016/j.ijpharm.2020.119379.
   PubMedGoogle Scholar
• Wang C, Han Z, Wu Y, Lu X, Tang X, Xiao J, Li N. 2021. Enhancing stability and anti-inflammatory properties of curcumin in ulcerative colitis therapy using liposomes mediated colon-specific drug delivery system. Food Chem Toxicol. 151:112123. doi: 10.1016/j.fct.2021.112123.
   PubMed Web of Science ®Google Scholar
• Wang J, Yadav V, Smart AL, Tajiri S, Basit AW. 2015. Stability of peptide drugs in the colon. Eur J Pharm Sci. 78:31–36. doi: 10.1016/j.ejps.2015.06.018.
   PubMed Web of Science ®Google Scholar
• Wu C, Kuo Y, Hong R, Wu H. 2015. α Enolase–binding peptide enhances drug delivery efficiency and therapeutic efficacy against colorectal cancer. Sci Transl Med. 7(290):290ra91. doi: 10.1126/scitranslmed.aaa9391.
   PubMed Web of Science ®Google Scholar
• Xian J, Zhong X, Gu H, Wang X, Li J, Li J, Wu Y, Zhang C, Zhang J. 2021. Colonic delivery of celastrol-loaded layer-by-layer liposomes with pectin/trimethylated chitosan coating to enhance its anti-ulcerative colitis effects. Pharmaceutics. 13(12):2005. doi: 10.3390/pharmaceutics13122005.
   PubMed Web of Science ®Google Scholar
• Xian S, Zhu J, Wang Y, Song H, Wang H. 2023. Oral liposomal delivery of an activatable budesonide prodrug reduces colitis in experimental mice. Drug Deliv. 30(1):2183821. doi: 10.1080/10717544.2023.2183821.
   PubMed Web of Science ®Google Scholar
• Yadav V, House A, Matiz S, McCoubrey LE, Bettano KA, Bhave L, Wang M, Fan PW, Zhou S, Woodhouse JD, et al. 2022. Ileocolonic-targeted JAK inhibitor: a safer and more effective treatment for inflammatory bowel disease. Pharmaceutics. 14(11):2385. doi: 10.3390/pharmaceutics14112385.
   PubMed Web of Science ®Google Scholar
• Yang C, Merlin D. 2019. Nanoparticle-mediated drug delivery systems for the treatment of ibd: current perspectives. Int J Nanomedicine. 14:8875–8889. doi: 10.2147/ijn.s210315.
   PubMed Web of Science ®Google Scholar
• Zhang M, Merlin D. 2018. Nanoparticle-based oral drug delivery systems targeting the colon for treatment of ulcerative colitis. Inflamm Bowel Dis. 24(7):1401–1415. doi: 10.1093/ibd/izy123.
   PubMed Web of Science ®Google Scholar
• Zhao J, Hao S, Chen Y, Ye X, Fang P, Hu H. 2024. Tauroursodeoxycholic acid liposome alleviates DSS-induced ulcerative colitis through restoring intestinal barrier and gut microbiota. Colloids Surf B Biointerfaces. 236:113798. doi: 10.1016/j.colsurfb.2024.113798.
   PubMed Web of Science ®Google Scholar